ロード中...
Considerations for the Next Clinical Trial Evaluating the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
Trials SWOG 8949 and EORTC 30947 had the same eligibility criteria and established the role of cytoreductive nephrectomy for metastatic renal cell carcinoma. The more recently published CARMENA trial calls into question the need for cytoreductive nephrectomy. A systematic comparison of CARMENA and S...
保存先:
| 出版年: | Eur Urol Focus |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6858992/ https://ncbi.nlm.nih.gov/pubmed/31103605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.euf.2019.05.006 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|